Figure 2
From: TCL1A expression delineates biological and clinical variability in B-cell lymphoma
Oncomine analysis of TCL1A in non-Hodgkin's lymphoma: (a) Differential expression of TCL1A in lymphoma types: Burkitt's lymphoma (HIV+), diffuse large B-cell lymphoma (centroblastic), diffuse large B-cell lymphoma (immunoblastic), diffuse large B-cell lymphoma, hairy-cell Leukemia, Burkitt's lymphoma, follicular lymphoma, B-cells, mantle cell lymphoma, and chronic lymphocytic leukemia, respectively (www.oncomine.org). Data link source: http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE2350.26 (b) TCL1A expression in diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia. Data link sources: http://llmpp.nih.gov/lymphoma/analysis.shtml, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60.35
